Skip to main content
Top

Journal of Endocrinological Investigation

Issue 4/2022

Content (26 Articles)

Review

Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis

V. Andreasi, C. Ricci, S. Partelli, G. Guarneri, C. Ingaldi, F. Muffatti, S. Crippa, R. Casadei, M. Falconi

Overweight Original Article

Responsiveness on metabolic syndrome criteria and hepatic parameters after 12 weeks and 24 weeks of multidisciplinary intervention in overweight adolescents

N. Leite, M. C. Tadiotto, P. R. P. Corazza, F. J. de Menezes Junior, M. E. C. Carli, G. E. Milano-Gai, W. A. Lopes, A. R. Gaya, C. Brand, J. Mota, R. B. Radominski

COVID-19 Original Article

Low testosterone predicts hypoxemic respiratory insufficiency and mortality in patients with COVID-19 disease: another piece in the COVID puzzle

W. Vena, A. Pizzocaro, G. Maida, M. Amer, A. Voza, A. Di Pasquale, F. Reggiani, M. Ciccarelli, C. Fedeli, D. Santi, E. Lavezzi, A. G. Lania, G. Mazziotti

Testosterone Original Article

The association between 2,4-D and serum testosterone levels: NHANES 2013–2014

F. E. Glover, F. Del Giudice, F. Belladelli, P. B. Ryan, T. Chen, M. L. Eisenberg, W. M. Caudle

Hyperparathyroidism Original Article

The impact of age on quality of life and frailty outcomes after parathyroidectomy in patients with primary hyperparathyroidism

T. S. Papavramidis, P. Anagnostis, I. Pliakos, G. Tzikos, A. Chorti, K. Kotsa, A. Michalopoulos

Dexamethasone Original Article

Screening for drugs potentially interfering with MCT8-mediated T3 transport in vitro identifies dexamethasone and some commonly used drugs as inhibitors of MCT8 activity

C. Di Cosmo, G. De Marco, P. Agretti, E. Ferrarini, A. Dimida, P. Falcetta, S. Benvenga, P. Vitti, M. Tonacchera

COVID-19 Original Article

Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS-CoV-2 disease

C. Sparano, E. Zago, A. Morettini, C. Nozzoli, D. Yannas, V. Adornato, E. Caldini, M. Vaudo, M. Maggi, L. Petrone

Obesity Original Article

Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case–control study

T. Feola, G. Puliani, F. Sesti, R. Modica, R. Centello, R. Minotta, G. Cannavale, S. Di Meglio, V. Di Vito, R. Lauretta, M. Appetecchia, A. Colao, A. Lenzi, A. M. Isidori, A. Faggiano, E. Giannetta

Subacute thyroiditis during the COVID-19 pandemic: a prospective study

A. B. Bahçecioğlu, Z. C. Karahan, B. İ. Aydoğan, İ. A. Kalkan, A. Azap, M. F. Erdoğan

Vaccination Rapid Communication

Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves’ disease to silent thyroiditis

A. Pujol, L.-A. Gómez, C. Gallegos, J. Nicolau, P. Sanchís, M. González-Freire, Á. A. López-González, K. Dotres, L. Masmiquel

Opinion

Salt reduction and iodine intake in Italy

A. Olivieri, F. Giorgino, C. Maffeis, M. Bagnasco

Open Access Consensus Statement

Delphi consensus on the diagnosis and treatment of patients with short stature in Spain: GROW-SENS study

R. Corripio-Collado, C. Fernández-Ramos, I. González-Casado, F. Moreno-Macián, J.-P. López-Siguero, J.-I. Labarta-Aizpún

Testosterone Correction

Correction to: The association between 2,4‑D and serum testosterone levels: NHANES 2013–2014

F. E. Glover, F. Del Giudice, F. Belladelli, P. B. Ryan, T. Chen, M. L. Eisenberg, W. M. Caudle

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine